The landscape of dementia prognosis has evolved considerably with the appearance of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-centered checks that may detect Alzheimer's pathology a long time ahead of indications arise. Though these technological advances signify exceptional progress in knowledge neurodegenerative disorder